Nature Communications (Nov 2020)

Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer’s disease mouse model

  • Xufeng Cen,
  • Yanying Chen,
  • Xiaoyan Xu,
  • Ronghai Wu,
  • Fusheng He,
  • Qingwei Zhao,
  • Qiming Sun,
  • Cong Yi,
  • Jie Wu,
  • Ayaz Najafov,
  • Hongguang Xia

DOI
https://doi.org/10.1038/s41467-020-19547-6
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 13

Abstract

Read online

Previous work suggests that mitophagy in neurons is could be therapeutic in Alzheimer’s disease (AD). Here, the authors screen a library of drugs and identify UMI-77, a mitophagy inducer with beneficial effects in an AD mouse model, by binding MCL-1, which they identify as a mitophagy receptor.